Ralf Adams and Hans Schöler elected into Review Boards of the Deutsche Forschungsgemeinschaft
More than 48,600 scientists voted
Approximately 150,000 scientists were entitled to vote and could decide on the occupation of 613 seats in a total of 48 Review Boards for the 2016 to 2019 term of office via the online voting system. Three days after the 4 weeks elections closed, the preliminary results are known.
According to these preliminary voting results of the Deutsche Forschungsgemeinschaft (DFG), Ralf Adams and Hans Schöler of the Max Planck Institute for Molecular Biomedicine were elected into the Review Boards Developmental Biology and Cell Biology, resp.
Both directors of the Max Planck Institute for Molecular Biomedicine are pleased that their scientific colleagues have confidence in their judgment.
The main responsibility of review board members is to scientifically evaluate funding proposals, submitted to the Deutsche Forschungsgemeinschaft (DFG) in their respective subject areas and thus ensure that all proposals within a given subject area are assessed using a common standard. The review board members write a final recommendation that is submitted to the relevant decision-making body of the DFG together with the proposals.
The review boards also advise the DFG's statutory bodies on strategic issues relating to research funding. The review boards also work on an interdisciplinary basis, both in terms of research funding and on strategic matters.